| scholarly article | Q13442814 |
| P50 | author | Amanda L Reilly | Q87908745 |
| Caroline Buckee | Q91546354 | ||
| Andrew S. Azman | Q55456306 | ||
| Corey M Peak | Q56554183 | ||
| P2860 | cites work | Modelling measles re-emergence as a result of waning of immunity in vaccinated populations | Q58027519 |
| Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q71922829 | ||
| Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics | Q74598644 | ||
| Vaccination against cholera in Juba | Q87928627 | ||
| Oral cholera vaccine campaign among internally displaced persons in South Sudan | Q95384391 | ||
| Vaccination and herd immunity to infectious diseases | Q39835584 | ||
| Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. | Q40088781 | ||
| Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial | Q40295575 | ||
| Effects of the infectious period distribution on predicted transitions in childhood disease dynamics | Q41554504 | ||
| Computation of epidemic final size distributions | Q41604696 | ||
| Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis | Q44716334 | ||
| First 5 years of measles elimination in southern Africa: 1996-2000. | Q46692288 | ||
| Herd immunity: basic concept and relevance to public health immunization practices. 1971. | Q48899187 | ||
| Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. | Q52243115 | ||
| Imperfect vaccines and herd immunity to HIV. | Q52393161 | ||
| Reactive vaccination in the presence of disease hotspots | Q56762397 | ||
| Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up | Q57936163 | ||
| Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity | Q27302088 | ||
| Herd immunity: history, theory, practice | Q28252852 | ||
| Inapparent infections and cholera dynamics. | Q30371386 | ||
| On the relative role of different age groups in influenza epidemics | Q30375953 | ||
| Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. | Q30382404 | ||
| Cholera--modern pandemic disease of ancient lineage | Q30409696 | ||
| Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections | Q30513891 | ||
| Quantifying travel behavior for infectious disease research: a comparison of data from surveys and mobile phones | Q30836435 | ||
| Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures | Q33981191 | ||
| Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial | Q34058784 | ||
| Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines | Q34216467 | ||
| The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks | Q34515249 | ||
| Mass vaccination: when and why. | Q34567662 | ||
| EPIDEMIOLOGICAL CONSEQUENCES OF IMPERFECT VACCINES FOR IMMUNIZING INFECTIONS. | Q35383503 | ||
| The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study | Q35754539 | ||
| Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials | Q35870576 | ||
| Mucosal immunity: implications for vaccine development | Q36117069 | ||
| Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study | Q36160401 | ||
| The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan | Q36288804 | ||
| Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011-2015. | Q36306115 | ||
| Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination | Q36366761 | ||
| Generalized reproduction numbers and the prediction of patterns in waterborne disease | Q36438457 | ||
| Cholera in Haiti: reproductive numbers and vaccination coverage estimates | Q36522758 | ||
| Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014. | Q36935225 | ||
| Fractional dosing of yellow fever vaccine to extend supply: a modelling study | Q39192916 | ||
| Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis | Q39448785 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| herd immunity | Q736798 | ||
| P304 | page(s) | e0006257 | |
| P577 | publication date | 2018-02-28 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects | |
| P478 | volume | 12 |
| Q92172377 | Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice |
| Q100426221 | Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006-2018 |
| Q100395018 | The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology |
| Q92909970 | Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country |
Search more.